{"id":949297,"date":"2026-04-06T19:08:38","date_gmt":"2026-04-06T23:08:38","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-aquestive-therapeutics-inc-aqst-nektar-therapeutics-nktr-and-eos-energy-ente\/"},"modified":"2026-04-06T19:08:38","modified_gmt":"2026-04-06T23:08:38","slug":"holzer-holzer-llc-reminds-investors-of-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-aquestive-therapeutics-inc-aqst-nektar-therapeutics-nktr-and-eos-energy-ente","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-aquestive-therapeutics-inc-aqst-nektar-therapeutics-nktr-and-eos-energy-ente\/","title":{"rendered":"Holzer &amp; Holzer, LLC Reminds Investors of Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Aquestive Therapeutics, Inc. (AQST), Nektar Therapeutics (NKTR), and Eos Energy Enterprises, Inc. (EOSE)"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">ATLANTA, April  06, 2026  (GLOBE NEWSWIRE) &#8212; Holzer &amp; Holzer, LLC reminds investors of the deadline to seek to be appointed lead plaintiff in the following class action lawsuits:<\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <u>Aquestive Therapeutics, Inc. (AQST)<\/u><br \/>\n        <\/strong>\n      <\/p>\n<p align=\"justify\">The shareholder class action lawsuit filed against Aquestive Therapeutics, Inc. (\u201cAquestive\u201d) (NASDAQ: AQST) alleges that Defendants made materially false and\/or misleading statements and\/or failed to disclose material facts regarding Aquestive\u2019s New Drug Application for Anaphylm between <strong>June 16, 2025 and January 8, 2026<\/strong>. If you purchased Aquestive shares during this time period and suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nU6y85SSKVfVBi_UvebwyeXSRvQmsutcKQheAX1Pg2a64ExLMYiVxBaFmPPXw_M-_6w6ezUNEbpTLbxTVuXidbuTh34OU5LqxvyIGiVVMck=\" rel=\"nofollow\" target=\"_blank\">cholzer@holzerlaw.com<\/a>, by toll-free telephone at (888) 508-6832 or you may visit the firm\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4wRrR3--XSga7OIARI5l0bzPkeVSUZbyQeTpzfIrUk0hWEQeYMUeKc_TyXv4xqhr5ZFKMJLTVfhwYCGRvJVY-Gomkkwpe4OtFiZYRBuMG35DMevInZ153UdHX9HiPLixdOvCg7QwYIiaqYJg4Aqmz7Wt0nD1sH-g4sikC2BSxb8=\" rel=\"nofollow\" target=\"_blank\">www.holzerlaw.com\/case\/aquestive-therapeutics\/<\/a> to learn more.<\/p>\n<p align=\"justify\">\n        <strong>The deadline to ask the court to be appointed lead plaintiff in the case is\u00a0May 4, 2026.<\/strong>\n      <\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <u>Nektar Therapeutics (NKTR)<\/u><br \/>\n        <\/strong>\n      <\/p>\n<p align=\"justify\">The shareholder class action lawsuit filed against Nektar Therapeutics (\u201cNektar\u201d) (NASDAQ: NKTR) alleges that Defendants made materially false and\/or misleading statements and\/or failed to disclose material facts regarding Nektar\u2019s REZOLVE-AA trial between <strong>February 26, 2025 and December 15, 2025<\/strong>. If you purchased Nektar shares during this time period and suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nU6y85SSKVfVBi_UvebwyeXSRvQmsutcKQheAX1Pg2aVwnsFZlU-QpP0SYOeLNq6M8qFcWJ0ORpg2Ce51cOIMcjZX1L01At1M6ia_HDyWr0=\" rel=\"nofollow\" target=\"_blank\">cholzer@holzerlaw.com<\/a>, by toll-free telephone at (888) 508-6832 or you may visit the firm\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4wRrR3--XSga7OIARI5l0bzPkeVSUZbyQeTpzfIrUk21MSdytMGygiqfJPgSpb887sIb014mtxwJ_FRhy49XhfZHuSdkktNC6DQuky5diRi7RGHGi40_RfPIO6WpaXzpfonwO-FSeqbUupWciCDJC4P-HS8bF-UpyJWbux2HKJQ=\" rel=\"nofollow\" target=\"_blank\">www.holzerlaw.com\/case\/nektar-therapeutics\/<\/a> to learn more.<\/p>\n<p align=\"justify\">\n        <strong>The deadline to ask the court to be appointed lead plaintiff in the case is May 5, 2026.<\/strong>\n      <\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <u>Eos Energy Enterprises, Inc. (EOSE)<\/u><br \/>\n        <\/strong>\n      <\/p>\n<p align=\"justify\">The shareholder class action lawsuit filed against Eos Energy Enterprises, Inc. (\u201cEos Energy\u201d or the \u201cCompany\u201d) (NASDAQ: EOSE) alleges that Defendants made materially false and\/or misleading statements and\/or failed to disclose material facts regarding Eos Energy\u2019s ability to achieve the ramp in production and capacity utilization required to achieve its previously set guidance between <strong>November 5, 2025 and February 26, 2026<\/strong>. If you purchased Eos Energy shares during this time period and suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nU6y85SSKVfVBi_UvebwyeXSRvQmsutcKQheAX1Pg2YCEwe18pG7MpYs7VOGW2ux1rQ11wFNqmx_jNSv74FdPuhI493znyYb42w9c-nOvnE=\" rel=\"nofollow\" target=\"_blank\">cholzer@holzerlaw.com<\/a>, by toll-free telephone at (888) 508-6832 or you may visit the firm\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4wRrR3--XSga7OIARI5l0bzPkeVSUZbyQeTpzfIrUk1VBHeRPhpWDBiFRpYvdj3gbPHYE_HkE5ghU4bpuXxQa4HWy0o8e1MAnn7YiPsrK4Vei7SamO78DGlN68aWjk3p-1joo63YUDGjl3gmPKWmml-_XkzQmwme57iqfezI_nE=\" rel=\"nofollow\" target=\"_blank\">www.holzerlaw.com\/case\/eos-energy-enterprises\/<\/a> to learn more.<\/p>\n<p align=\"justify\">\n        <strong>The deadline to ask the court to be appointed lead plaintiff in the case is May 5, 2026.<\/strong>\n      <\/p>\n<p align=\"justify\">Holzer &amp; Holzer, LLC, an ISS top rated securities litigation law firm for 2021, 2022, 2023, and 2025, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer &amp; Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct.\u202fMore information about the firm is available through its website, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=lHqrnemUomPkyhLdbV9lRpHDInw778aDUqs2qA2_ZEkZgudVvWSAxRLvV_VJVQyA3hzyjeMdtZ7YWMOP2wvEkzs52liMVq-A3ZnvEI2wTic=\" rel=\"nofollow\" target=\"_blank\">https:\/\/holzerlaw.com\/<\/a>,\u202fand upon request from the firm. Holzer &amp; Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content.\u202f\u00a0<\/p>\n<p align=\"justify\">CONTACT:<br \/>Corey Holzer, Esq.<br \/>(888) 508-6832 (toll-free) <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nU6y85SSKVfVBi_UvebwyeXSRvQmsutcKQheAX1Pg2brbBlaKBS3PT5aTaBzUKlYF7VSzNgPaP8mPx-ryf_PdHXytV20ytmShJlQ5-GFKpw=\" rel=\"nofollow\" target=\"_blank\">cholzer@holzerlaw.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NDg0MCM3NTIxNzg3IzIxODA3Njc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MmY2MDZjMzctMmYxNC00Mjc3LWJlMjAtMTk2Njc0ODg4YmE1LTExOTIzMzYtMjAyNi0wNC0wNi1lbg==\/tiny\/Holzer-Holzer.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>ATLANTA, April 06, 2026 (GLOBE NEWSWIRE) &#8212; Holzer &amp; Holzer, LLC reminds investors of the deadline to seek to be appointed lead plaintiff in the following class action lawsuits: Aquestive Therapeutics, Inc. (AQST) The shareholder class action lawsuit filed against Aquestive Therapeutics, Inc. (\u201cAquestive\u201d) (NASDAQ: AQST) alleges that Defendants made materially false and\/or misleading statements and\/or failed to disclose material facts regarding Aquestive\u2019s New Drug Application for Anaphylm between June 16, 2025 and January 8, 2026. If you purchased Aquestive shares during this time period and suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at cholzer@holzerlaw.com, by toll-free telephone at (888) 508-6832 or you may visit the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-aquestive-therapeutics-inc-aqst-nektar-therapeutics-nktr-and-eos-energy-ente\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Holzer &amp; Holzer, LLC Reminds Investors of Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Aquestive Therapeutics, Inc. (AQST), Nektar Therapeutics (NKTR), and Eos Energy Enterprises, Inc. (EOSE)&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-949297","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Holzer &amp; Holzer, LLC Reminds Investors of Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Aquestive Therapeutics, Inc. (AQST), Nektar Therapeutics (NKTR), and Eos Energy Enterprises, Inc. (EOSE) - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-aquestive-therapeutics-inc-aqst-nektar-therapeutics-nktr-and-eos-energy-ente\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Holzer &amp; Holzer, LLC Reminds Investors of Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Aquestive Therapeutics, Inc. (AQST), Nektar Therapeutics (NKTR), and Eos Energy Enterprises, Inc. (EOSE) - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ATLANTA, April 06, 2026 (GLOBE NEWSWIRE) &#8212; Holzer &amp; Holzer, LLC reminds investors of the deadline to seek to be appointed lead plaintiff in the following class action lawsuits: Aquestive Therapeutics, Inc. (AQST) The shareholder class action lawsuit filed against Aquestive Therapeutics, Inc. (\u201cAquestive\u201d) (NASDAQ: AQST) alleges that Defendants made materially false and\/or misleading statements and\/or failed to disclose material facts regarding Aquestive\u2019s New Drug Application for Anaphylm between June 16, 2025 and January 8, 2026. If you purchased Aquestive shares during this time period and suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at cholzer@holzerlaw.com, by toll-free telephone at (888) 508-6832 or you may visit the &hellip; Continue reading &quot;Holzer &amp; Holzer, LLC Reminds Investors of Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Aquestive Therapeutics, Inc. (AQST), Nektar Therapeutics (NKTR), and Eos Energy Enterprises, Inc. (EOSE)&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-aquestive-therapeutics-inc-aqst-nektar-therapeutics-nktr-and-eos-energy-ente\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-06T23:08:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NDg0MCM3NTIxNzg3IzIxODA3Njc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/holzer-holzer-llc-reminds-investors-of-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-aquestive-therapeutics-inc-aqst-nektar-therapeutics-nktr-and-eos-energy-ente\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/holzer-holzer-llc-reminds-investors-of-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-aquestive-therapeutics-inc-aqst-nektar-therapeutics-nktr-and-eos-energy-ente\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Holzer &amp; Holzer, LLC Reminds Investors of Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Aquestive Therapeutics, Inc. (AQST), Nektar Therapeutics (NKTR), and Eos Energy Enterprises, Inc. (EOSE)\",\"datePublished\":\"2026-04-06T23:08:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/holzer-holzer-llc-reminds-investors-of-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-aquestive-therapeutics-inc-aqst-nektar-therapeutics-nktr-and-eos-energy-ente\\\/\"},\"wordCount\":541,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/holzer-holzer-llc-reminds-investors-of-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-aquestive-therapeutics-inc-aqst-nektar-therapeutics-nktr-and-eos-energy-ente\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4NDg0MCM3NTIxNzg3IzIxODA3Njc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/holzer-holzer-llc-reminds-investors-of-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-aquestive-therapeutics-inc-aqst-nektar-therapeutics-nktr-and-eos-energy-ente\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/holzer-holzer-llc-reminds-investors-of-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-aquestive-therapeutics-inc-aqst-nektar-therapeutics-nktr-and-eos-energy-ente\\\/\",\"name\":\"Holzer &amp; Holzer, LLC Reminds Investors of Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Aquestive Therapeutics, Inc. (AQST), Nektar Therapeutics (NKTR), and Eos Energy Enterprises, Inc. (EOSE) - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/holzer-holzer-llc-reminds-investors-of-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-aquestive-therapeutics-inc-aqst-nektar-therapeutics-nktr-and-eos-energy-ente\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/holzer-holzer-llc-reminds-investors-of-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-aquestive-therapeutics-inc-aqst-nektar-therapeutics-nktr-and-eos-energy-ente\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4NDg0MCM3NTIxNzg3IzIxODA3Njc=\",\"datePublished\":\"2026-04-06T23:08:38+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/holzer-holzer-llc-reminds-investors-of-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-aquestive-therapeutics-inc-aqst-nektar-therapeutics-nktr-and-eos-energy-ente\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/holzer-holzer-llc-reminds-investors-of-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-aquestive-therapeutics-inc-aqst-nektar-therapeutics-nktr-and-eos-energy-ente\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/holzer-holzer-llc-reminds-investors-of-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-aquestive-therapeutics-inc-aqst-nektar-therapeutics-nktr-and-eos-energy-ente\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4NDg0MCM3NTIxNzg3IzIxODA3Njc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4NDg0MCM3NTIxNzg3IzIxODA3Njc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/holzer-holzer-llc-reminds-investors-of-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-aquestive-therapeutics-inc-aqst-nektar-therapeutics-nktr-and-eos-energy-ente\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Holzer &amp; Holzer, LLC Reminds Investors of Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Aquestive Therapeutics, Inc. (AQST), Nektar Therapeutics (NKTR), and Eos Energy Enterprises, Inc. (EOSE)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Holzer &amp; Holzer, LLC Reminds Investors of Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Aquestive Therapeutics, Inc. (AQST), Nektar Therapeutics (NKTR), and Eos Energy Enterprises, Inc. (EOSE) - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-aquestive-therapeutics-inc-aqst-nektar-therapeutics-nktr-and-eos-energy-ente\/","og_locale":"en_US","og_type":"article","og_title":"Holzer &amp; Holzer, LLC Reminds Investors of Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Aquestive Therapeutics, Inc. (AQST), Nektar Therapeutics (NKTR), and Eos Energy Enterprises, Inc. (EOSE) - Market Newsdesk","og_description":"ATLANTA, April 06, 2026 (GLOBE NEWSWIRE) &#8212; Holzer &amp; Holzer, LLC reminds investors of the deadline to seek to be appointed lead plaintiff in the following class action lawsuits: Aquestive Therapeutics, Inc. (AQST) The shareholder class action lawsuit filed against Aquestive Therapeutics, Inc. (\u201cAquestive\u201d) (NASDAQ: AQST) alleges that Defendants made materially false and\/or misleading statements and\/or failed to disclose material facts regarding Aquestive\u2019s New Drug Application for Anaphylm between June 16, 2025 and January 8, 2026. If you purchased Aquestive shares during this time period and suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at cholzer@holzerlaw.com, by toll-free telephone at (888) 508-6832 or you may visit the &hellip; Continue reading \"Holzer &amp; Holzer, LLC Reminds Investors of Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Aquestive Therapeutics, Inc. (AQST), Nektar Therapeutics (NKTR), and Eos Energy Enterprises, Inc. (EOSE)\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-aquestive-therapeutics-inc-aqst-nektar-therapeutics-nktr-and-eos-energy-ente\/","og_site_name":"Market Newsdesk","article_published_time":"2026-04-06T23:08:38+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NDg0MCM3NTIxNzg3IzIxODA3Njc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-aquestive-therapeutics-inc-aqst-nektar-therapeutics-nktr-and-eos-energy-ente\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-aquestive-therapeutics-inc-aqst-nektar-therapeutics-nktr-and-eos-energy-ente\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Holzer &amp; Holzer, LLC Reminds Investors of Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Aquestive Therapeutics, Inc. (AQST), Nektar Therapeutics (NKTR), and Eos Energy Enterprises, Inc. (EOSE)","datePublished":"2026-04-06T23:08:38+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-aquestive-therapeutics-inc-aqst-nektar-therapeutics-nktr-and-eos-energy-ente\/"},"wordCount":541,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-aquestive-therapeutics-inc-aqst-nektar-therapeutics-nktr-and-eos-energy-ente\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NDg0MCM3NTIxNzg3IzIxODA3Njc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-aquestive-therapeutics-inc-aqst-nektar-therapeutics-nktr-and-eos-energy-ente\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-aquestive-therapeutics-inc-aqst-nektar-therapeutics-nktr-and-eos-energy-ente\/","name":"Holzer &amp; Holzer, LLC Reminds Investors of Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Aquestive Therapeutics, Inc. (AQST), Nektar Therapeutics (NKTR), and Eos Energy Enterprises, Inc. (EOSE) - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-aquestive-therapeutics-inc-aqst-nektar-therapeutics-nktr-and-eos-energy-ente\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-aquestive-therapeutics-inc-aqst-nektar-therapeutics-nktr-and-eos-energy-ente\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NDg0MCM3NTIxNzg3IzIxODA3Njc=","datePublished":"2026-04-06T23:08:38+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-aquestive-therapeutics-inc-aqst-nektar-therapeutics-nktr-and-eos-energy-ente\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-aquestive-therapeutics-inc-aqst-nektar-therapeutics-nktr-and-eos-energy-ente\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-aquestive-therapeutics-inc-aqst-nektar-therapeutics-nktr-and-eos-energy-ente\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NDg0MCM3NTIxNzg3IzIxODA3Njc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NDg0MCM3NTIxNzg3IzIxODA3Njc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-aquestive-therapeutics-inc-aqst-nektar-therapeutics-nktr-and-eos-energy-ente\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Holzer &amp; Holzer, LLC Reminds Investors of Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Aquestive Therapeutics, Inc. (AQST), Nektar Therapeutics (NKTR), and Eos Energy Enterprises, Inc. (EOSE)"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/949297","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=949297"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/949297\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=949297"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=949297"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=949297"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}